Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2000
11/16/2000WO2000038625A3 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000DE19922407A1 Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373121A1 Vector-mediated delivery of integrating transposon sequences
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372624A1 Improved method for treating mammals with modified mammalian blood
11/16/2000CA2371265A1 Materials for soft tissue augmentation and methods of making and using same
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1052285A2 Method of inducing an antigen-specific anticytotoxic cell
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051207A1 Radiopaque implantable collagenous biomaterial device
11/15/2000EP1051206A1 A multi-formed collagenous biomaterial medical device
11/15/2000EP1051191A2 Cd154 blockade therapy for pancreatic islet tissue transplantation
11/15/2000EP1051187A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/15/2000EP1051186A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
11/15/2000EP1051142A1 A new powerful cosmetic or pharmaceutical composition
11/15/2000EP1051116A1 Embolization device
11/15/2000EP1011694A4 Conditioning for allogeneic stem cell transplantation
11/15/2000EP0717635B1 Methods for regulating gastrointestinal motility
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/15/2000CN1273532A Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same
11/15/2000CN1273125A Chinese medicine containing ant for treating rheumatism and its preparing process
11/15/2000CN1273122A Synthetic orall liquid of red sage root
11/15/2000CN1273118A Chinese medicine for treating dental disease and its preparing process `
11/15/2000CN1273107A Xinnaofukang capsule-for treating angiocardiopathy and cerebrovascular disease and its preparing process
11/15/2000CN1273104A Chinese medicine for treating hepatitis B and hepatic fibrosis and its preparing process
11/15/2000CN1273103A Chinese-medicinal pill for treating hepatism
11/15/2000CN1273101A Thermal picking for recovery of hyperosteogeny and protrusion of intervertebral disc
11/15/2000CN1273097A Bacillus preparation and its preparing process and usage
11/15/2000CN1273096A Process for extracting sheep placenta extract
11/15/2000CN1058409C Medicine for treatment of osteoproliferation
11/15/2000CN1058408C Nasitis powder and producing process thereof
11/15/2000CN1058404C Medicine for treatment of hepatitis B
11/15/2000CN1058400C Reinforcing kidney and supporting yang medicine
11/15/2000CN1058394C Method for pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ
11/15/2000CN1058393C Extraction method of scorpion toxin crystal
11/15/2000CN1058392C Disinfecting anti-inflammatory pill and preparing method
11/14/2000US6147276 Quiescent cell populations for nuclear transfer in the production of non-human mammals and non-human mammalian embryos
11/14/2000US6147230 Amino acid dysiherbaine
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6146890 Method and system for cultivating macrophages
11/14/2000US6146889 Proliferation of hepatocyte precursors
11/14/2000US6146885 Plasmid for transfer of genes into vertebrate cells
11/14/2000US6146870 Flea protease proteins
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146623 A gene therapy for treating cancer
11/09/2000WO2000066759A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/09/2000WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000WO2000066752A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066720A2 The use of adeno-associated virus (aav) deliver cytoprotective genes
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066716A2 Method for producing organisms exhibiting increased sterol glycoside production and use of the sterol glycosides
11/09/2000WO2000066715A1 Method for diminishing specific immune reactions
11/09/2000WO2000066714A2 Shiga-like toxin as an enriching and purging agent
11/09/2000WO2000066713A2 Materials and methods relating to neuronal development
11/09/2000WO2000066188A2 Xenotransplant for cns therapy
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066177A1 GENE THERAPY USING TGF-$g(b)
11/09/2000WO2000066162A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000WO2000066158A2 Use of cytokines and mitogens to inhibit pathological immune responses
11/09/2000WO2000066155A1 Methods for preventing reactivation of latent virus and controlling virus replication
11/09/2000WO2000066147A1 A method of inducing formation of kidney epithelia from mesenchymal precursors
11/09/2000WO2000066071A1 Biomimetic water solutions and compositions, their use as and in health and beauty care products and the methods to prepare them
11/09/2000WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue
11/09/2000WO2000066036A2 Fabrication of vascularized tissue using microfabricated two-dimensional molds
11/09/2000WO2000066028A1 Compositions for freezing dog sperm, method of freezing the dog sperm utilizing the compositions and artificial insemination method employing the frozen dog sperm
11/09/2000WO2000041713A3 Composition and method for improving function of embryonic kidney transplants
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000034455A3 Methods and systems useful for transferring genes into pancreatic islets ex vivo and into the pancreas in vivo
11/09/2000WO2000034443A3 Megakaryocyte-induced expansion of hematopoietic stem cells
11/09/2000WO2000031238A3 Methods and reagents for increasing proliferative capacity and preventing replicative senescence
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000029553A9 Bioengineered tissue constructs and methods for producing and using them
11/09/2000WO2000027999A9 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
11/09/2000DE19921027A1 Verbindungen mit antibiotischer Wirkung Compounds with antibiotic activity
11/09/2000CA2727692A1 Isoflavone metabolites
11/09/2000CA2373045A1 Gene therapy using tgf-.beta.
11/09/2000CA2372956A1 Use of cytokines and mitogens to inhibit pathological immune responses
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2371577A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000CA2371260A1 Materials and methods relating to neuronal development
11/09/2000CA2370781A1 Fabrication of vascularized tissue using microfabricated two-dimensional molds
11/09/2000CA2369747A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000CA2368748A1 X-ray guided drug delivery
1 ... 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 ... 1259